Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$10.9 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARVN Arvinas, Inc.	$333M	$11,000 0.0% of portfolio	1,600	Q1 2025 New
ACAD Acadia Pharmaceuticals Inc	$2.85B	$10,000 0.0% of portfolio	649	Q4 2024 Added 44.22%
LXRX Lexicon Pharmaceuticals, Inc.	$102M	$9,000 0.0% of portfolio	21,323	Q1 2025 Added 5,230.75%
SRRK Scholar Rock Holding Corp	$1.56B	$8,000 0.0% of portfolio	276	Q1 2025 New
VERA Vera Therapeutics, Inc.	$574M	$8,000 0.0% of portfolio	350	Q4 2024 New
DRTS Alpha Tau Medical Ltd.	$187M	$8,000 0.0% of portfolio	3,550	Q4 2024 Reduced 41.32%
WVE Wave Life Sciences Ltd.	$549M	$8,000 0.0% of portfolio	1,050	Q1 2025 Reduced 12.5%
AMLX Amylyx Pharmaceuticals, Inc.	$287M	$7,000 0.0% of portfolio	2,000	Q4 2023 Reduced 9.09%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.62B	$7,000 0.0% of portfolio	605	Q4 2024 Added 98.36%
OCUL Ocular Therapeutix, Inc	$547M	$7,000 0.0% of portfolio	1,000	Q3 2023 Reduced 78.19%
CGEN Compugen LTD	$121M	$7,000 0.0% of portfolio	5,202	Q2 2024 Added 48.63%
GERN Geron Corp	$457M	$6,000 0.0% of portfolio	4,000	Q2 2024 Added 100.0%
LGND Ligand Pharmaceuticals Inc	$1.75B	$6,000 0.0% of portfolio	61	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.21B	$5,000 0.0% of portfolio	300	Q4 2023 New
HRMY Harmony Biosciences Holdings, Inc.	$2.03B	$5,000 0.0% of portfolio	170	Q3 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.88B	$5,000 0.0% of portfolio	126	Q4 2024 Added 26.0%
BCRX Biocryst Pharmaceuticals Inc	$1.9B	$4,000 0.0% of portfolio	600	Q1 2025 New
RGNX Regenxbio Inc.	$374M	$4,000 0.0% of portfolio	663	Q1 2025 Added 152.09%
ATNM Actinium Pharmaceuticals, Inc.	$40.3M	$3,000 0.0% of portfolio	2,000	Q3 2024 New
IMCR Immunocore Holdings PLC	$1.28B	$3,000 0.0% of portfolio	112	Q4 2024 Added 12.0%
NTLA Intellia Therapeutics, Inc.	$613M	$3,000 0.0% of portfolio	477	Q1 2025 Reduced 66.94%
NVAX Novavax Inc	$492M	$3,000 0.0% of portfolio	530	Q1 2025 Reduced 14.38%
CVM Cel Sci Corp	$9.54M	$2,000 0.0% of portfolio	10,604	Q1 2025 Added 0.04%
DAWN Day One Biopharmaceuticals, Inc.	$453M	$2,000 0.0% of portfolio	300	Q1 2025 New
FULC Fulcrum Therapeutics, Inc.	$348M	$2,000 0.0% of portfolio	790	Q2 2024 Reduced 52.78%
HRTX Heron Therapeutics, Inc.	$226M	$2,000 0.0% of portfolio	1,000	Q4 2024 Reduced 9.91%
INMB Inmune Bio, Inc.	$139M	$2,000 0.0% of portfolio	350	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$506M	$2,000 0.0% of portfolio	231	Q4 2023 New
ENLV Enlivex Therapeutics Ltd.	$18.8M	$2,000 0.0% of portfolio	2,500	Q4 2024 Reduced 16.67%
SLGL Sol Gel Technologies Ltd.	$170M	$2,000 0.0% of portfolio	5,160	Q4 2024 Added 24.04%
ANVS Annovis Bio, Inc.	$14.5M	$1,000 0.0% of portfolio	1,000	Q1 2025 New
BDTX Black Diamond Therapeutics, Inc.	$70.5M	$1,000 0.0% of portfolio	1,200	Q1 2025 Reduced 20.79%
FDMT 4 D Molecular Therapeutics, Inc.	$106M	$1,000 0.0% of portfolio	500	Q1 2025 New
GMAB Genmab A/S	$12.9B	$1,000 0.0% of portfolio	80	Q3 2024 Added 5.26%
GOSS Gossamer Bio, Inc.	$98.7M	$1,000 0.0% of portfolio	1,000	Q4 2024 New
TSVT 2seventy Bio, Inc.	$189M	$1,000 0.0% of portfolio	239	Q1 2025 Reduced 55.66%
VIR Vir Biotechnology, Inc.	$604M	$1,000 0.0% of portfolio	300	Q1 2025 New
VYGR Voyager Therapeutics, Inc.	$127M	$1,000 0.0% of portfolio	400	Q4 2021 Reduced 81.4%
BYSI Beyond Spring Inc.	$65M	$1,000 0.0% of portfolio	1,080	Q1 2025 New
AGIO Agios Pharmaceuticals, Inc.	$1.55B	$0 0.0% of portfolio	9	Q1 2020 Reduced 99.01%
AIM Aim Immuno Tech Inc.	$3.84M	$0 0.0% of portfolio	220	Q1 2025 New
ALLK Allakos Inc.	$28M	$0 0.0% of portfolio	1,500	Q1 2023 New
AXSM Axsome Therapeutics, Inc.	$4.6B	$0 0.0% of portfolio	4	Q4 2024 New
BCYC Bicycle Therapeutics PLC	$241M	$0 0.0% of portfolio	10	Q4 2024 New
SAVA Cassava Sciences Inc	$82.2M	$0 0.0% of portfolio	112	Q4 2024 Added 49.33%
CMRX Chimerix Inc	$748M	$0 0.0% of portfolio	25	Q1 2025 New
DNLI Denali Therapeutics Inc.	$1.9B	$0 0.0% of portfolio	25	Q4 2024 New
EDIT Editas Medicine, Inc.	$96.2M	$0 0.0% of portfolio	525	Q4 2024 Added 23.53%
ERAS Erasca, Inc.	$155M	$0 0.0% of portfolio	200	Q1 2025 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	19	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.